Clinical Trials
CSL Behring begins pediatric Phase III hemophilia B study...
CSL Behring has commenced the patient enrollment in pivotal pediatric Phase III hemophilia B study of recombinant fusion protein linking coagulation factor IX with...
Clinical Trials
GlycoMimetics completes enrollment in Phase 2 study of GMI-1070
Clinical-stage biotechnology company GlycoMimetics has completed patient enrollment for the Phase 2 sickle cell disease study evaluating GMI-1070. Hospitalized sickle...
Clinical Trials
Kiadis Pharma raises fund for Phase II study of...
Kiadis Pharma has raised EUR10m in a financing round to conduct Phase II study of a cell based medicinal product candidate, ATIR, and to...
Clinical Trials
Pfizer Phase 3 fibromyalgia study of pregabalin meets primary...
Pfizer Phase III study of pregabalin controlled-release (CR) formulation has met primary endpoint of time to loss of therapeutic response (LTR), in fibromyalgia patients....
Clinical Trials
Idera completes patient enrollment in Phase 2 trial of...
Idera Pharmaceuticals has concluded enrolling patients in double-blind, placebo-controlled Phase 2 trial assessing IMO-3100 in psoriasis patients. The study randomized...
Clinical Trials
Novavax pandemic influenza vaccine meets endpoints in two Phase...
Novavax A/H5N1 avian influenza vaccine candidate has met safety and immunogenicity endpoints in two Phase 1 clinical trials. The trials...
Clinical Trials
Hybrigenics starts phase II clinical trial of inecalcitol in...
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.